… Accordingly, there are multiple avenues macrophage metabolism can be targeted to relieve
immune suppression in pancreatic cancer, and ongoing studies in this area aim to exploit …

… pancreatitis to pancreatic cancer. Thus, the role of fibrosis in the crosstalk between pancreatitis
and pancreatic cancer is critical … of pancreatic fibrosis in inflammation and cancer, and we …

… development and progression has led to the development of potential targeted therapies
for pancreatic cancer, some of which appear to be promising and exhibit synergistic efficacy in …

… , and pancreatic neuroendocrine tumors. Pancreatic cancer in this review is considered
pancreatic … Herein, in this review, a new target for chemotherapy with pronounced involvement in …

… Pancreatic disorders cause a broad spectrum of clinical diseases, mainly including acute and
chronic pancreatitis and pancreatic cancer, … Unfortunately, the pathogenesis of pancreatic …

… of cancer death by 2030 [Citation1–Citation3]. Notably, the absolute number of new cases
and deaths due to pancreatic cancer … and pancreatic cancer accounts for 7.3% of all cancer …

… targeted therapies exist — further underscore that pancreatic … information related to pancreatic
cancer genomics with the … a unifying description of the life history of pancreatic cancer. …

… of pancreatic cancer. We briefly introduce the most groundbreaking advances in pancreatic
cancer … Targeting ZIP4 might be a novel treatment strategy for PC patients with dysregulated …

… In summary, targeting cancer stem cells or EMT-phenotype cells by regulating miRNAs could
be a novel strategy for achieving improved treatment outcomes for patients diagnosed with …

… tumor growth in various types of cancer, especially those driven by oncogenic mutations
in RAS or RAF, such as lung cancer, pancreatic cancer, and melanoma, where autophagy is …